AstraZeneca Pharma India has informed that Robert Haxton has resigned as the Wholetime Director of the company. The Board has accepted the resignation of Haxton and that he would be relieved from the said position, effective December 14, 2014.
The above information is a part of company’s filings submitted to BSE.